Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective studyMaliazurina B. Saad, Jia Wu, Kang Qin et al.|The Lancet Digital Health|2023Cited by 108
Sleeve resection after neoadjuvant chemoimmunotherapy in the treatment of locally advanced non-small cell lung cancerJie Dai, Gening Jiang, Xinsheng Zhu et al.|Translational Lung Cancer Research|2022Cited by 19
Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacitiesDavid B. Nelson, Mara B. Antonoff|Journal of Thoracic Disease|2020Cited by 8